Chemed Co. (NYSE:CHE) Director Walter L. Krebs sold 2,910 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $430.41, for a total transaction of $1,252,493.10. Following the transaction, the director now directly owns 9,318 shares of the company’s stock, valued at $4,010,560.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
CHE opened at $423.96 on Friday. The company has a quick ratio of 0.78, a current ratio of 0.81 and a debt-to-equity ratio of 0.25. The firm has a 50 day moving average price of $399.09 and a 200-day moving average price of $347.10. Chemed Co. has a twelve month low of $260.03 and a twelve month high of $441.48. The stock has a market capitalization of $6.94 billion, a price-to-earnings ratio of 34.35, a PEG ratio of 2.97 and a beta of 1.14.
Chemed (NYSE:CHE) last announced its earnings results on Thursday, July 25th. The company reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.09 by $0.27. The company had revenue of $473.60 million during the quarter, compared to analyst estimates of $471.72 million. Chemed had a net margin of 10.94% and a return on equity of 35.63%. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the business posted $2.81 earnings per share. As a group, analysts expect that Chemed Co. will post 13.54 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 3rd. Investors of record on Monday, August 12th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.30%. This is a positive change from Chemed’s previous quarterly dividend of $0.30. The ex-dividend date is Friday, August 9th. Chemed’s payout ratio is 10.73%.
Several research analysts have recently weighed in on CHE shares. Royal Bank of Canada boosted their price objective on shares of Chemed to $405.00 and gave the company a “sector perform” rating in a report on Monday, July 29th. ValuEngine raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, June 7th. Zacks Investment Research cut shares of Chemed from a “hold” rating to a “sell” rating in a report on Thursday, May 9th. Finally, Oppenheimer boosted their price objective on shares of Chemed from $400.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. One analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company’s stock. Chemed currently has an average rating of “Hold” and an average price target of $383.75.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Quadrant Capital Group LLC grew its position in Chemed by 184.8% during the first quarter. Quadrant Capital Group LLC now owns 94 shares of the company’s stock valued at $26,000 after buying an additional 61 shares during the period. Krane Funds Advisors LLC bought a new stake in Chemed during the second quarter valued at approximately $26,000. Bremer Bank National Association bought a new stake in Chemed during the first quarter valued at approximately $29,000. Advisory Services Network LLC grew its position in Chemed by 117.9% during the second quarter. Advisory Services Network LLC now owns 85 shares of the company’s stock valued at $30,000 after buying an additional 46 shares during the period. Finally, Cullen Frost Bankers Inc. bought a new stake in Chemed during the first quarter valued at approximately $60,000. Institutional investors own 87.14% of the company’s stock.
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.